Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI

Sílvia D. Almeida,João Santinha,Francisco P. M. Oliveira,Joana Ip,Maria Lisitskaya,João Lourenço,Aycan Uysal,Celso Matos,Cristina João,Nikolaos Papanikolaou
DOI: https://doi.org/10.1186/s40644-020-0286-5
IF: 5.605
2020-01-13
Cancer Imaging
Abstract:Abstract Background Whole-body diffusion weighted imaging (WB-DWI) has proven value to detect multiple myeloma (MM) lesions. However, the large volume of imaging data and the presence of numerous lesions makes the reading process challenging. The aim of the current study was to develop a semi-automatic lesion segmentation algorithm for WB-DWI images in MM patients and to evaluate this smart-algorithm (SA) performance by comparing it to the manual segmentations performed by radiologists. Methods An atlas-based segmentation was developed to remove the high-signal intensity normal tissues on WB-DWI and to restrict the lesion area to the skeleton. Then, an outlier threshold-based segmentation was applied to WB-DWI images, and the segmented area’s signal intensity was compared to the average signal intensity of a low-fat muscle on T1-weighted images. This method was validated in 22 whole-body DWI images of patients diagnosed with MM. Dice similarity coefficient (DSC), sensitivity and positive predictive value (PPV) were computed to evaluate the SA performance against the gold standard (GS) and to compare with the radiologists. A non-parametric Wilcoxon test was also performed. Apparent diffusion coefficient (ADC) histogram metrics and lesion volume were extracted for the GS segmentation and for the correctly identified lesions by SA and their correlation was assessed. Results The mean inter-radiologists DSC was 0.323 ± 0.268. The SA vs GS achieved a DSC of 0.274 ± 0.227, sensitivity of 0.764 ± 0.276 and PPV 0.217 ± 0.207. Its distribution was not significantly different from the mean DSC of inter-radiologist segmentation ( p = 0.108, Wilcoxon test). ADC and lesion volume intraclass correlation coefficient (ICC) of the GS and of the correctly identified lesions by the SA was 0.996 for the median and 0.894 for the lesion volume ( p < 0.001). The duration of the lesion volume segmentation by the SA was, on average, 10.22 ± 0.86 min, per patient. Conclusions The SA provides equally reproducible segmentation results when compared to the manual segmentation of radiologists. Thus, the proposed method offers robust and efficient segmentation of MM lesions on WB-DWI. This method may aid accurate assessment of tumor burden and therefore provide insights to treatment response assessment.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the challenge of quantifying tumor burden by whole - body diffusion weighted imaging (WB - DWI) in patients with multiple myeloma (MM). Specifically, due to the large amount of imaging data and a large number of lesions, the manual assessment process is very challenging. Therefore, the main objective of the study is to develop an atlas - based semi - automatic lesion segmentation algorithm for WB - DWI images of MM patients and evaluate the performance of this smart algorithm (SA) by comparing it with the manual segmentation results of radiologists. The specific problems mentioned in the paper include: 1. **Large amount of data**: The whole - body image contains a large amount of data, which increases the difficulty of reading and analyzing. 2. **Large number of lesions**: MM patients may have multiple lesions, which complicates the manual quantification of the total lesion burden. 3. **Inconsistency of manual segmentation**: There are large differences in the manual segmentation results among different radiologists, which affect the consistency and accuracy of the evaluation. To meet these challenges, the researchers have developed a new smart algorithm, aiming to quickly and accurately segment the lesion area, thereby assisting radiologists to more efficiently quantify the tumor burden, which is of great significance for evaluating the treatment response.